Germany
· Delayed Price · Currency is EUR United Therapeutics Company Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients.
It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin.
In addition, the company involved in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products.
It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag.
United Therapeutics Corporation was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
| Country | United States |
| Founded | 1996 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,305 |
| CEO | Martine Rothblatt |
Contact Details
Address: 1000 Spring Street Silver Spring, Delaware 20910 United States | |
| Phone | 301 608 9292 |
| Website | unither.com |
Stock Details
| Ticker Symbol | UTH |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Martine Rothblatt | Chief Executive Officer |
| James Edgemond | Chief Financial Officer |
| Michael Benkowitz | Chief Operating Officer |
| Harrison Silvers | Head of Investor Relations |